Real-time enrollment status for this mild to moderate asthma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:56 PM UTC
| NCT Number | NCT07330778 |
| Recruiting Status | Recruiting |
| Condition | Mild to Moderate Asthma |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Celldex Therapeutics |
| Last Updated on CT.gov | July 2, 2026 (Jul 2, 2026) |
As of August 29, 2026: Clinical trial NCT07330778 is currently recruiting participants. This phase1 study for mild to moderate asthma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Celldex Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07330778 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07330778 was last updated Jul 2, 2026 (July 2, 2026). HelloStudys verifies this status automatically.